MRI correlates of disability in African-Americans with multiple sclerosis

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Howard, Jonathan ^a   Battaglini, Marco ^b   Babb, James Scott ^a   Arienzo, Donatello ^a   Holst, Brigitte ^a,c   Omari, Mirza ^a   de Stefano, Nicola ^b   Herbert, Joseph ^a   Inglese, Matilde ^a,d  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETA 1B BETASERON; BETA INTERFERON; BETA LA AVONEX; BETA LA REBIFF; BETA1A INTERFERON; GADOLINIUM; GADOLINIUM PENTETATE; GLATIRAMER; IMMUNOGLOBULIN; INTERFERON BETA SERINE; MITOXANTRONE; NATALIZUMAB; REBIFF; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; AGE; AMBULATORY CARE; ARTICLE; BRAIN DAMAGE; BRAIN SIZE; DISABILITY; DISEASE DURATION; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; FEMALE; GENDER; GRAY MATTER; HUMAN; IMAGE ANALYSIS; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; WHITE MATTER;

ADULT; AFRICAN AMERICANS; BRAIN; DISABILITY EVALUATION; DISABLED PERSONS; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; ORGAN SIZE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84864999162     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043061     Document Type: Article

References (12)

1. Wallin MT, Page WF, Kurtzke JF, ((2004)) Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography. Ann Neurol 55:: 65--71.
2. Naismith RT, Trinkaus K, Cross AH, ((2006)) Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review. Mult Scler12:: 775--781.
3. Cree BA, Khan O, Bourdette D, Goodin DS, Cohen JA, et al. ((2004)) Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology 63:: 2039--2045.
4. Kister I, Chamot E, Bacon JH, Niewczyk PM, De Guzman RA, et al. ((2010)) Rapid disease course in African Americans with multiple sclerosis. Neurology 75:: 217--223.
5. Weinstock-Guttman B, Ramanathan M, Hashmi K, Abdelrahman N, Hojnacki D, et al. ((2010)) Increased tissue damage and lesion volumes in African Americans with multiple sclerosis. Neurology 74:: 538--544.
6. Miller DH, Barkhof F, Frank JA, Parker GJ, Thompson AJ, ((2002)) Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 125:: 1676--1695.
7. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, et al. ((2005)) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58:: 840--846.
8. Inglese M, Madelin G, Oesingmann N, Babb JS, Wu W, et al. ((2010)) Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla. Brain 133:: 847--857.
9. Battaglini M, Jenkinson M, De Stefano N (2011). Evaluating and reducing the impact of white matter lesions on brain volume measurements. Hum Brain Mapp Epub ahead of print.
10. Rinker JR 2nd, Trinkaus K, Naismith RT, Cross AH, ((2007)) Higher IgG index found in African Americans versus Caucasians with multiple sclerosis. Neurology 69:: 68--72.
11. Gelfand JM, Cree BA, McElroy J, Oksenberg J, Green R, et al. ((2011)) Vitamin D in African Americans with multiple sclerosis. Neurology 76:: 1824--1830.
12. Isamah N, Faison W, Payne ME, MacFall J, Steffens DC,et al. (2010). Variability in frontotemporal brain structure: the importance of recruitment of African Americans in neuroscience research. PLoS One 5: e13642. Epub ahead of print.